Single-cell RNA sequencing reveals potential therapeutic targets in the tumor microenvironment of lung squamous cell...

Area of Science:

• Oncology
• Immunology
• Genomics

Background:

• Lung squamous cell carcinoma (LUSC) research is limited by poor understanding of its molecular drivers.
• LUSC accounts for a significant portion of lung cancer diagnoses.

Purpose of the Study:

• To analyze the tumor microenvironment (TME) composition in LUSC using single-cell RNA sequencing (scRNA-seq).
• To identify distinct malignant cell phenotypes (meta-programs, MPs) and their clinical relevance in LUSC.
• To explore potential therapeutic targets within identified MPs for personalized LUSC treatment.

Main Methods:

• Analysis of public LUSC datasets from two cohorts.
• Application of non-negative matrix factorization (NMF) for gene expression pattern analysis.
• Survival analysis to assess the clinical impact of identified MPs.

Main Results:

• Identification of unique malignant cell phenotypes (MPs) in LUSC.
• Characterization of the TME, noting enrichment of CD8+ T, exhausted T, CD4+ T, and naive T cells.
• Observed roles for myeloid cells (cDC1, pDCs) in LUSC progression and highlighted MP-driven heterogeneity.
• Demonstrated clinical relevance and implications of identified MPs.

Conclusions:

• The identified MPs underscore LUSC heterogeneity and offer potential for targeted therapies, particularly for early-stage disease.
• Insights into immune cell dynamics within the TME can guide novel LUSC treatment strategies.
• This research supports enhanced early intervention, personalized medicine, and improved prognostic accuracy for LUSC patients.